SAGE Therapeutics' Grant

SAGE Therapeutics raised a round of funding on July 31, 2013. Investors include National Institutes of Health.

SAGE Therapeutics is a neuroscience-focused company developing medicines to treat rare and orphan diseases of the central nervous system (CNS). SAGE's lead program, SAGE-547, is in clinical developmen…

Articles about SAGE Therapeutics' Grant: